New Hampshire Lawmakers Take Up Bipartisan Bills To Legalize Psilocybin For Medical Use
New Jersey Marijuana Businesses Could Engage In Interstate Commerce Under Senate President’s New Bill
Ohio Attorney General Rejects Cannabis Referendum Petition, Saying It’s ‘Misleading’
Canadian Support For Marijuana Legalization Is Increasing, New Poll Shows
Joe Rogan Surprised After GOP Senator Says Marijuana And Alcohol Industries Jointly Backed Push To Ban Hemp THC Products
More Than A Third Of Rap And Hip Hop Music Videos Feature Marijuana, Government-Funded Study Shows
CBD Has ‘Substantial Promise’ To Combat Tumors From Cancer, Scientific Review Shows
Marijuana Users Are Being Unjustly Jailed For Allegedly Driving Under The Influence, Government-Funded Study Shows
California Officials Award $30 Million In Marijuana Revenue To Support Research On THC Drinks, Terpenes And Tribal Cannabis Sales
Medical Marijuana Use Is ‘Prevalent’ Among People With Disabilities—And It Helps Treat Pain, New Federally Funded Study Shows
State Marijuana Regulators Share Tips On How To Stay Safe And Legal Around The Holidays
One In Three Americans ‘Pre-Game’ With Marijuana Before Family Holiday Gatherings, Survey Finds
As More Americans Choose Marijuana Over Alcohol, Mainstream Media Notices The ‘Cousin Walk’ Thanksgiving Tradition
Joe Rogan Slams ‘Really Bad’ Federal Hemp Ban Trump Signed, Blaming Alcohol Industry For Influencing Congress
New Netflix Documentary Shows How Psychedelics Help Military Veterans Heal Trauma
Pre-Rolls Are A Key Driver Of The Cannabis Retail Market’s Success (Op-Ed)
Massachusetts Hits $10 Billion Marijuana Sales Milestone, With Top Official Saying Consumption Lounges Will Bolster Industry In 2026
Ohio Dispensaries Sold More Than $1 Billion Worth Of Legal Marijuana In 2025
Marijuana Consumers Are More Likely To Shop At Target Following Decision To Sell Cannabis-Infused Drinks, Poll Shows
Marijuana Company Sues DoorDash, Total Wine And Others Over Alleged Illegal Sales Of Hemp THC Products
Federal hemp THC ban would be delayed for two years under new bill (Newsletter: January 14, 2026)
Congress moves to keep blocking cannabis sales in DC (Newsletter: January 13, 2026)
DOJ won’t delay cannabis rescheduling, GOP congressman says (Newsletter: January 12, 2026)
Federal medical cannabis protections approved in Congress (Newsletter: January 9, 2026)
Trump drug czar pushed to back full cannabis legalization (Newsletter: January 8, 2026)
Published
on
By
New Jersey’s Senate president has filed a bill that would allow marijuana companies to engage in interstate commerce.
Under the proposal from Sen. Nicholas Scutari (D), the governor would be empowered to “enter into an agreement with another state or states authorizing medicinal or personal-use commercial cannabis activity, or both, between entities licensed under the laws of the contracting state and entities operating with a State license” in New Jersey.
However, the reform would only take effect under certain conditions, such as if federal law changed to explicitly allow interstate marijuana commerce, the U.S. Department of Justice issued a memo saying it would tolerate the activity or if Congress passed legislation blocking officials from enforcing the prohibition on cannabis sales between states.
Alternatively, the policy could move forward if the state attorney general issued an opinion determining that the law’s implementation “will not result in significant legal risk to this State based on review of federal judicial decisions and administrative action.”
Cannabis products brought into the state from another market under the bill’s framework would need to be subject rules equivalent to New Jersey’s regulations, including with respect to testing, packaging, labeling, marketing, tracking and quality assurance.
Scutari has introduced interstate cannabis commerce legislation in previous sessions, but none of those proposals were enacted into law.
Several other states already have interstate marijuana commerce laws in place.
California Gov. Gavin Newsom (D), for example, signed a bill in 2022 that empowers him to enter into interstate cannabis commerce agreements with other legal states, but that power is incumbent upon federal guidance or an assessment from the state attorney general that sanctioned such activity.
Following a review of the policy proposal, however, California Attorney General Rob Bonta’s (D) office ultimately determined in 2023 that the state could put itself and its employees at “significant legal risk” of federal enforcement action if it were to authorize interstate marijuana commerce.
Oregon and Washington State have also passed laws allowing officials to enter into cross-border cannabis trade agreements with other states, although those state laws both require some form of federal reform or guidance to proceed.
Meanwhile, lawmakers in Congress have filed legislation intended to help small marijuana growers compete against large corporations in the event of federal legalization—proposing to give them the ability to ship and sell cannabis products directly to consumers within and across state lines via the U.S. Postal Service (USPS) and commercial carriers.
Back in New Jersey, lawmakers this week sent Gov. Phil Murphy (D) a bill to create a psilocybin therapy pilot program and allocate $6 million in funding to support the effort.
In other New Jersey drug policy news, voters in November elected U.S. Rep. Mikie Sherrill (D-NJ) to serve as the state’s next governor, and there’s now a decidedly clearer path to advancing a marijuana reform long awaited by consumers and advocates in the Garden State: A home grow option.
Meanwhile, as New Jersey’s first marijuana consumption lounges opened up over the summer, regulators shared information about where to find the sites and offering tips about how to responsibly use cannabis at the licensed businesses—including classic stoner cultural customs like “puff, puff, pass.”
New Jersey officials have also completed the curriculum of a no-cost marijuana training academy that’s meant to support entrepreneurs interested in entering the cannabis industry.
Tom Angell is the editor of Marijuana Moment. A 25-year veteran in the cannabis and drug law reform movement, he covers the policy and politics of marijuana, psychedelics and other substances. He previously reported for Forbes, Marijuana.com and MassRoots, and was given the Hunter S. Thompson Media Award by NORML and has been named Journalist of the Year by Americans for Safe Access. As an activist, Tom founded the nonprofit Marijuana Majority and handled media relations, campaigns and lobbying for Law Enforcement Against Prohibition and Students for Sensible Drug Policy.
Add Marijuana Moment as a preferred source on Google.
All the cannabis news you need, all in one place. Copyright © 2017-2026 Marijuana Moment LLC ® and Tom Angell
